X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4) 4
animals (3) 3
index medicus (3) 3
oncology (3) 3
abridged index medicus (2) 2
aged (2) 2
analysis (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
chemotherapy (2) 2
expression (2) 2
immunology (2) 2
lymphomas (2) 2
medicine & public health (2) 2
mice (2) 2
middle aged (2) 2
non-hodgkins-lymphoma (2) 2
prospective studies (2) 2
respiratory system (2) 2
adoptive transfer (1) 1
adult (1) 1
advanced follicular lymphoma (1) 1
aged, 80 and over (1) 1
antibodies, monoclonal, murine-derived - administration & dosage (1) 1
antibodies, monoclonal, murine-derived - adverse effects (1) 1
antigen presentation - immunology (1) 1
antigen-presenting cells (1) 1
antigens, neoplasm - immunology (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antitumor immunity (1) 1
arterial-hypertension (1) 1
b-cell (1) 1
bendamustine (1) 1
bendamustine hydrochloride (1) 1
bone marrow (1) 1
bone-marrow (1) 1
breast-cancer (1) 1
cancer (1) 1
cancer research (1) 1
cancer vaccines (1) 1
carcinoma, lewis lung - immunology (1) 1
carcinoma, lewis lung - pathology (1) 1
carcinoma, lewis lung - prevention & control (1) 1
carcinoma, non-small-cell lung - metabolism (1) 1
carcinoma, non-small-cell lung - pathology (1) 1
care and treatment (1) 1
cell fusion (1) 1
cell line, tumor (1) 1
cell proliferation - drug effects (1) 1
cells, cultured (1) 1
chemotherapy plus rituximab (1) 1
chop chemotherapy (1) 1
class-i (1) 1
combination (1) 1
comparative analysis (1) 1
cox-2 inhibitors (1) 1
critical care medicine (1) 1
cyclic-amp generation (1) 1
cyclooxygenase 1 - metabolism (1) 1
cyclooxygenase 2 - metabolism (1) 1
cyclooxygenase inhibitors - pharmacology (1) 1
cyclophosphamide (1) 1
cyclophosphamide - administration & dosage (1) 1
cyclophosphamide - adverse effects (1) 1
cytotoxic t-lymphocytes (1) 1
daily filgrastim (1) 1
dendritic cells (1) 1
dendritic cells - immunology (1) 1
dendritic cells - pathology (1) 1
development and progression (1) 1
diffuse large b-cell lymphoma (1) 1
dinoprostone - analysis (1) 1
dinoprostone - secretion (1) 1
disease models, animal (1) 1
disease-free survival (1) 1
doxorubicin - administration & dosage (1) 1
doxorubicin - adverse effects (1) 1
drug therapy (1) 1
drug therapy, combination (1) 1
endotoxin (1) 1
epidermal growth factor (1) 1
epithelial-cells (1) 1
female (1) 1
filgrastim (1) 1
fusions (1) 1
gene expression regulation - drug effects (1) 1
granulocyte colony-stimulating factor - pharmacokinetics (1) 1
granulocyte colony-stimulating factor - therapeutic use (1) 1
growth-factor receptor (1) 1
health care sciences & services (1) 1
helicobacter-pylori (1) 1
hematology (1) 1
hematopoiesis (1) 1
human lung-cancer (1) 1
hybrid cells - immunology (1) 1
hybrids (1) 1
hypertension, pulmonary - drug therapy (1) 1
ii multicenter (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9873, pp. 1203 - 1210
Summary Background Rituximab plus chemotherapy, most often CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), is the first-line standard of... 
Internal Medicine | SURVIVAL | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | II MULTICENTER | B-CELL | ADVANCED FOLLICULAR LYMPHOMA | CYCLOPHOSPHAMIDE | VINCRISTINE | NON-HODGKINS-LYMPHOMA | COMBINATION | CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Nitrogen Mustard Compounds - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Vincristine - administration & dosage | Adult | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Prednisone - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Treatment Outcome | Nitrogen Mustard Compounds - adverse effects | Disease-Free Survival | Bendamustine Hydrochloride | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Aged | Infusions, Intravenous | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Usage | Chemotherapy | Bendamustine | Patient outcomes | Lymphomas | Research | Drug therapy | Comparative analysis | Cancer | Antimitotic agents | Care and treatment | Antineoplastic agents | Analysis | Bone marrow | Hematology
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 2/2013, Volume 62, Issue 2, pp. 309 - 320
Lung cancer is frequently complicated by pulmonary infections which may impair prognosis of this disease. Therefore, we investigated the effect of bacterial... 
Infection | Immunology | Medicine & Public Health | Lung cancer | Tumor proliferation | Oncology | Cancer Research | Inflammation | Endotoxin | PROSTAGLANDIN BIOSYNTHESIS | HUMAN LUNG-CANCER | IMMUNOLOGY | GROWTH-FACTOR RECEPTOR | EPITHELIAL-CELLS | ONCOLOGY | MOUSE MODEL | TOLL-LIKE RECEPTORS | HELICOBACTER-PYLORI | LIPOPOLYSACCHARIDE LPS | TUMOR-GROWTH | EXPRESSION | Dinoprostone - analysis | Dinoprostone - secretion | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Nitrobenzenes - pharmacology | Lipopolysaccharides - immunology | Lipopolysaccharide Receptors - metabolism | Receptor, Epidermal Growth Factor - metabolism | Membrane Proteins - metabolism | Toll-Like Receptor 4 - antagonists & inhibitors | Disease Models, Animal | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Non-Small-Cell Lung - metabolism | Sulfonamides - pharmacology | Toll-Like Receptor 4 - metabolism | Indomethacin - pharmacology | Cyclooxygenase Inhibitors - pharmacology | Animals | Membrane Proteins - antagonists & inhibitors | Cyclooxygenase 2 - metabolism | Lipopolysaccharides - pharmacology | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Ki-67 Antigen - biosynthesis | Cell Proliferation - drug effects | Mice | Cyclooxygenase 1 - metabolism | COX-2 inhibitors | Prostaglandins | Epidermal growth factor | Analysis | Development and progression | Universities and colleges | Lung cancer, Non-small cell | Tumors | Original
Journal Article
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.